Blinatumomab is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: the Bologna Compassionate Program Experience

Publication date: September 2016 Source:Clinical Lymphoma Myeloma and Leukemia, Volume 16, Supplement 2 Author(s): Cristina Papayannidis, Stefania Paolini, Alessandra Santoro, Valentina Robustelli, Simona Soverini, Caterina De Benedittis, Enrica Imbrogno, Carolina Terragna, Andrea Ghelli Luserna di Rora, Sarah Parisi, Chiara Sartor, Giovanni Marconi, Silvia Lomonaco, Maria Chiara Abbenante, Giovanni Martinelli

Source: Clinical Lymphoma Myeloma and Leukemia - September 20, 2016 Category: Cancer & Oncology Source Type: research